Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (381-390 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHAZhijian Zhao, David D Wisnoski, Julie A O'Brien, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 ReceptorRobert M Garbaccio, Edward J Brnardic, Mark E Fraley, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 4: potent and orally bioavailable chain-shortened RGD mimeticsPaul J Coleman, Ben C Askew, John H Hutchinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2012
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation ratesVadim Y Dudkin, Keith Rickert, Constantine Kreatsoulas, et al.
Angiogenesis|January 5, 2025
Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitorAnbukkarasi Muniyandi, Gabriella D Hartman, Kamakshi Sishtla, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesiaPeter J Manley, Amy Zartman, Daniel V Paone, et al.
Chemical Science|June 24, 2021
Bridging photochemistry and photomechanics with NMR crystallography: the molecular basis for the macroscopic expansion of an anthracene ester nanorodKevin R Chalek, Xinning Dong, Fei Tong, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptideRobert S Meissner, James J Perkins, Le T Duong, et al.
Pageof 46

Showing results (381-390 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHAZhijian Zhao, David D Wisnoski, Julie A O'Brien, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 ReceptorRobert M Garbaccio, Edward J Brnardic, Mark E Fraley, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 4: potent and orally bioavailable chain-shortened RGD mimeticsPaul J Coleman, Ben C Askew, John H Hutchinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2012
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation ratesVadim Y Dudkin, Keith Rickert, Constantine Kreatsoulas, et al.
Angiogenesis|January 5, 2025
Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitorAnbukkarasi Muniyandi, Gabriella D Hartman, Kamakshi Sishtla, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesiaPeter J Manley, Amy Zartman, Daniel V Paone, et al.
Chemical Science|June 24, 2021
Bridging photochemistry and photomechanics with NMR crystallography: the molecular basis for the macroscopic expansion of an anthracene ester nanorodKevin R Chalek, Xinning Dong, Fei Tong, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptideRobert S Meissner, James J Perkins, Le T Duong, et al.
Pageof 46